Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

ZS Pharma seeks U.S. approval of ZS-9 for hyperkalemia

May 27, 2015

Daiichi Sankyo develops phosphate transporter inhibitors

May 22, 2015

Prostanoid EP2/3 agonist ONO-8055: a promising agent for underactive bladder

May 18, 2015

Angion Biomedica plans phase III trial of BB3 in delayed kidney graft function

May 18, 2015

Phosphate Therapeutics releases phase II results for PT-20 in hyperphosphatemia

May 8, 2015

Tenapanor fails to significantly reduce albuminuria in patients with CKD and type 2 diabetes

May 6, 2015

Recruitment initiated in phase II trial of CicloMulsion for acute kidney injury

April 28, 2015

Merck & Co. presents novel MR antagonists

April 16, 2015

Phase IIb trial of Nefecon for primary IgA nephropathy meets primary endpoint

April 14, 2015

Hydra Biosciences and Boehringer Ingelheim collaborate on TRP inhibitors for renal diseases

April 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 8, 2026.
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...